Abstract Epigenetic regulation plays an important role in cell fate reprogramming. Here, we found that inhibitors of epigenetic modifiers, including VPA, TSA, and 5‐Aza‐2'‐deoxycytidine, can induce phenotypic transformation from Jurkat cells into B‐cell‐like cells. When Jurkat cells were treated with 5‐Aza combined with VPA, B cell and stem cell marker
Wenjin Xi+11 more
wiley +1 more source
Chronic myeloid leukemia associated with impairment of hearing. [PDF]
Christopher K. Williams, O. Ogan
openalex +1 more source
Abstract Background Overweight and obesity are known risk factors for cancer. The aim of this study was to investigate associations of body mass index (BMI) and waist circumference (WC) with incidence of 27 site‐specific cancers stratified by sex and menopausal status accounting for non‐linearity.
Seonghye Kim+7 more
wiley +1 more source
Leukemia and risk of stroke: a Mendelian randomization analysis
Background Observational studies suggest an association between leukemia and stroke, but causality remains unclear. Certain leukemia types may increase stroke risk, but variations exist in stroke and mortality rates across leukemia subtypes.
Xiaoyao Yi+4 more
doaj +1 more source
Blastic phase of Ph1-positive chronic myeloid leukemia and t(3;21) [letter] [PDF]
Ana Aventín+2 more
openalex +1 more source
Highly Sensitive and Disposable DNA‐Based Electrochemical Biosensor for Detection of Daunorubicin
Herin, a flower‐like porous MnO2‐modified pencil graphite electrode (MnO2‐PGE) is developed for the electrochemical determination of the anticancer drug daunorubicin and its interaction with dsDNA. The developed electrochemical nanobiosensor has some advantages, such as easy‐to‐handle, cost‐effective, portable, less time‐consuming assay and disposable.
Mukerrem Findik+2 more
wiley +1 more source
A comparative study of dibromomannitol and busulfan in the treatment of chronic myeloid leukemia. A study of cancer and leukemia group B [PDF]
Richard T. Silver+7 more
openalex +1 more source
Abstract A modified controlled‐release sodium valproate formulation (VAL001, test) was compared with an approved enteric‐coated tablet formulation (Absenor, reference). Pharmacokinetics and safety/tolerability were evaluated in healthy subjects to bridge with positive efficacy results from an early‐phase patient trial of valproate in combination with ...
Nikhil Ahuja+8 more
wiley +1 more source
Does the breakpoint within the major breakpoint cluster region (M-bcr) influence the duration of the chronic phase in chronic myeloid leukemia? An analytical comparison of current literature [see comments] [PDF]
Ken Mills, Peter Benn, GD Birnie
openalex +3 more sources
Induction of Differentiation of Mouse Myeloid Leukemia M1 Cells by Serum of Patients with Chronic Myeloid Leukemia [PDF]
Junko Okabe‐Kado+7 more
openalex +1 more source